A decade of exploring the cancer epigenome - biological and translational implications.

Abstract

The past decade has highlighted the central role of epigenetic processes in cancer causation, progression and treatment. Next-generation sequencing is providing a window for visualizing the human epigenome and how it is altered in cancer. This view provides many surprises, including linking epigenetic abnormalities to mutations in genes that control DNA methylation, the packaging and the function of DNA in chromatin, and metabolism. Epigenetic alterations are leading candidates for the development of specific markers for cancer detection, diagnosis and prognosis. The enzymatic processes that control the epigenome present new opportunities for deriving therapeutic strategies designed to reverse transcriptional abnormalities that are inherent to the cancer epigenome.

• Authors: Stephen B Baylin, Peter A Jones
• Journal: Nature reviews. Cancer (Nat Rev Cancer) Vol. 11 Issue 10 Pg. 726-34 (Sep 23 2011) ISSN: 1474-1768 [Electronic] England
• PMID: 21941284 (Publication Type: Historical Article, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)

Topics

• Animals
• Epigenesis, Genetic
• Epigenomics (history)
• Genome
• History, 20th Century
• History, 21st Century
• Humans
• Neoplasms (drug therapy, genetics, history, metabolism)
• Translational Research, Biomedical (history)